Current Thoughts on Dementia

Current Thoughts on Dementia

From Risk Factors to Therapeutic Interventions

Ashraf, Ghulam Md; Uddin, Md. Sahab

Springer Verlag, Singapore

07/2022

624

Dura

Inglês

9789811676055

15 a 20 dias

1118

Descrição não disponível.
Risk Factors



? Apolipoprotein E (APOE)



? Histone modifications, demethylation, and microRNA regulation



? Triggering receptor expressed on myeloid cells 2 (TREM2)



? Brain-derived neurotrophic factor (BDNF)



? Bridging integrator 1 (BIN1)



? Protein tyrosine phosphatase 1B (PTP1B)



? Leptin signaling



? Insulin signaling



? Autophagic dysfunction



? Ubiquitin-proteasome system dysfunction



? Circadian dysfunction



? Endoplasmic Reticulum Stress



? Depression



? Normal pressure hydrocephalus



? Antiphospholipid antibodies



? Sex hormones



? Changes in blood factors



? Infection-induced systemic inflammation



? Microbiota



? Abdominal visceral fat



? Atypical microvascular morphology



? Plasma exosomes spread



? Changes in visual cortex



? Obesity, dyslipidemia, hyperglycemia and hypertension



? Environmental pollutions







Therapeutic Interventions



? NMDA receptor antagonists



? Calcium channel blockers



? Catecholamine



? Statins



? Immunotherapy



? Quitting smoking



? Physical activity



? Diet and nutrition



? Natural products as promising drug candidates



? Nanotechnological applications



? Electroacupuncture



? Repetitive transcranial magnetic stimulation



? Transcranial direct current stimulation



? Reminiscence therapy



? Reality orientation therapy



? Bright-light therapy



? Snoezelen multi-sensory stimulation



? Behavioral therapy



? Brain-computer interface applications



? Music therapy



? Hypoxic-hyperoxic training



? Cognitive rehabilitation



? Cognitive creativity



? Stem cell research
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Aging;Alzheimer's Disease;Dementia;Genetics;Mild Cognitive Impairment;Therapeutics